Investment Analysts’ Price Target Changes for December 11th (ATUS, AZO, BAX, BRZE, BSX, CCL, DXCM, EW, FERG, ISRG)

Investment Analysts’ price target changes for Wednesday, December 11th:

Altice USA (NYSE:ATUS) had its price target raised by Citigroup Inc. from $2.50 to $3.00. Citigroup Inc. currently has a buy rating on the stock.

AutoZone (NYSE:AZO) had its target price raised by Citigroup Inc. from $3,500.00 to $3,900.00. Citigroup Inc. currently has a buy rating on the stock.

AutoZone (NYSE:AZO) had its price target raised by Wells Fargo & Company from $3,450.00 to $3,750.00. They currently have an overweight rating on the stock.

Baxter International (NYSE:BAX) had its target price trimmed by Citigroup Inc. from $37.00 to $35.00. Citigroup Inc. currently has a neutral rating on the stock.

Braze (NASDAQ:BRZE) had its price target raised by Citigroup Inc. from $47.00 to $51.00. Citigroup Inc. currently has a buy rating on the stock.

Boston Scientific (NYSE:BSX) had its target price boosted by Citigroup Inc. from $98.00 to $107.00. Citigroup Inc. currently has a buy rating on the stock.

Carnival Co. & (NYSE:CCL) had its target price boosted by Citigroup Inc. from $28.00 to $30.00. They currently have a buy rating on the stock.

DexCom (NASDAQ:DXCM) had its target price boosted by Citigroup Inc. from $85.00 to $91.00. Citigroup Inc. currently has a buy rating on the stock.

Edwards Lifesciences (NYSE:EW) had its price target increased by Citigroup Inc. from $81.00 to $83.00. Citigroup Inc. currently has a buy rating on the stock.

Ferguson (NASDAQ:FERG) had its target price boosted by Berenberg Bank from $224.00 to $240.00. The firm currently has a buy rating on the stock.

Intuitive Surgical (NASDAQ:ISRG) had its price target raised by Citigroup Inc. from $567.00 to $640.00. They currently have a buy rating on the stock.

Integer (NYSE:ITGR) had its target price increased by Citigroup Inc. from $130.00 to $145.00. They currently have a neutral rating on the stock.

Johnson & Johnson (NYSE:JNJ) had its target price trimmed by Citigroup Inc. from $185.00 to $175.00. They currently have a buy rating on the stock.

Southwest Airlines (NYSE:LUV) had its price target raised by Sanford C. Bernstein from $30.00 to $33.00. The firm currently has a market perform rating on the stock.

Nevro (NYSE:NVRO) had its target price trimmed by Citigroup Inc. from $6.00 to $5.00. They currently have a neutral rating on the stock.

Ollie’s Bargain Outlet (NASDAQ:OLLI) had its target price boosted by Loop Capital from $110.00 to $120.00. Loop Capital currently has a buy rating on the stock.

Ollie’s Bargain Outlet (NASDAQ:OLLI) had its target price raised by Wells Fargo & Company from $95.00 to $105.00. Wells Fargo & Company currently has an equal weight rating on the stock.

Penumbra (NYSE:PEN) had its target price raised by Citigroup Inc. from $220.00 to $245.00. Citigroup Inc. currently has a neutral rating on the stock.

Insulet (NASDAQ:PODD) had its price target increased by Citigroup Inc. from $283.00 to $310.00. The firm currently has a buy rating on the stock.

Royal Caribbean Cruises (NYSE:RCL) had its price target boosted by Citigroup Inc. from $257.00 to $283.00. They currently have a buy rating on the stock.

Sight Sciences (NASDAQ:SGHT) had its target price cut by Citigroup Inc. from $5.80 to $4.60. The firm currently has a neutral rating on the stock.

Sutro Biopharma (NASDAQ:STRO) had its target price trimmed by Wells Fargo & Company from $5.00 to $4.00. They currently have an equal weight rating on the stock.

Stryker (NYSE:SYK) had its price target boosted by Citigroup Inc. from $411.00 to $450.00. They currently have a buy rating on the stock.

Tandem Diabetes Care (NASDAQ:TNDM) had its target price cut by Citigroup Inc. from $57.00 to $50.00. Citigroup Inc. currently has a buy rating on the stock.

Trimble (NASDAQ:TRMB) had its target price raised by Sanford C. Bernstein from $82.00 to $85.00. The firm currently has an outperform rating on the stock.